Merck Advances to Eighth Place in the 2012 Access to Medicine Index

03-Dec-2012 - Germany

Merck announced that it now ranks eighth in the Access to Medicine Index published by the Access to Medicine Foundation. Merck has moved up nine places compared to the 2010 ranking. Every two years, the Access to Medicine Index benchmarks twenty pharmaceutical companies on the different activities and initiatives in promoting access to medicines in low- and middle-income countries.

“Merck has moved up to eighth place in this year’s Index largely because it has provided more information about its tiered pricing, management strategy and single-drug donation programs,” the Access to Medicine Foundation cited as reason why Merck has moved up nine places.

“Today, our efforts have been well recognized by the Index and serve as a measuring tool to monitor Merck’s overall progress in the access to medicine field. We are committed to pursuing and further developing our Access to Health activities in the future to achieve sustainable health solutions to all,” said Stefan Oschmann, Executive Board Member of Merck and Head of the Merck Serono division.

The Access to Health initiative at Merck was launched in February 2011 and has identified access gaps and opportunities to better meet the needs of underserved patients. Merck’s Access to Health initiative aims at bringing added value to the
community at large, and is becoming an integral part of how Merck conducts business in a responsible, sustainable manner. Merck recognizes the complexity of bringing health solutions to the poor and understands that Access to Medicines Index objectives cannot be reached by the pharmaceutical industry alone. Complementarity, synergy and partnership among the different actors in health are needed to achieve a long-term impact and sustainable results.

https://www.bionity.com/en/news/140723/merck-advances-to-eighth-place-in-the-2012-access-to-medicine-index.html